Market Highlights
Osteosarcoma is a bone tumor that may occur in any bone of the body. Approximately 75% of cases, patients with osteosarcoma are between 15-25 years old. Male are more as often suffer from osteosarcoma than females.
Currently, chemotherapy for osteosarcoma is usually directed within prospective clinical trials. In drug treatment, doxorubicin is the first and most commonly used the drug for osteosarcoma patients. Cisplatin is the second most commonly used drug and is included in most of the protocols. High-dose methotrexate with leucovorin is the third most commonly used drug. These treatment methods are likely to boost the pharmaceutical industries resulting in the growth of the osteosarcoma market.
The global osteosarcoma market is expected to grow at a CAGR of 6.40% during the forecast period 2017-2023.
Taste the market data and market information presented through more than 128 market data tables and figures spread over 134 pages of the project report. Avail the in-depth table of content TOC & market synopsis on “Osteosarcoma market research report–Global forecast till 2023.”
Get Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/4412
Major Players in the Osteosarcoma Market
Some of the key players in the global market are Pfizer (U.S.), Novartis (U.S.), Spectrum Pharmaceuticals, Inc. (U.S.), Hikma Pharmaceuticals (U.K), Baxter (U.S.), Advaxis Inc., Bellicum Pharmaceuticals (U.S.), and Inc. Isofol Medical AB (Sweden).
Regional Analysis
The global osteosarcoma market consists of four regions: the Americas, Europe, Asia Pacific, and the Middle East & Africa.
Constantly increasing the patient population of cancer, increasing the number of cases in children, and increasing government support for research in the healthcare domain drive the Americas market growth and remains responsible for making it one of the largest global market.
Europe holds the second position in the market due to increasing development and more focus on healthcare domain. Countries such as Germany and France are investing more in research & development to develop new treatment methods for various types of cancer. According to the European Cancer Organization, incidence rates of cancer diseases including osteosarcoma have increased by 41% and 50% respectively between 1993-1995 and 2012-2014. It is one of the major factors responsible for the growth of the market in this region.
The Asia Pacific is expected to be the fastest growing region in the global osteosarcoma market owing to emerging player and focus of established players in this region. Moreover, developing countries such as India, China, and the Republic of Korea are focusing on research & development and minimizing barriers to drug approval, which is projected to boost the market growth in this region.
On the other hand, the Middle East & Africa owns the minimum market share of the osteosarcoma market due to less development in the healthcare services such as new and advanced diagnosis & treatment methods in healthcare domain.
Segmentation
The global osteosarcoma market is segmented on the basis of types, diagnosis, treatment, and end user.
On the basis of the types, it is further segmented into intramedullary osteosarcoma, juxtacortical osteosarcoma, and extra-skeletal osteosarcoma.
On the basis of the diagnosis, the market is segmented into biopsy, X-ray, MRI, CT Scan, bone scan, and others.
On the basis of the treatment, the market is segmented into chemotherapy, surgery, radiation therapy, and others.
On the basis of the end user, the market is segmented into hospitals & clinics, cancer research centers, and others.
Table Of Content
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
4.5 Technology Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power Of Suppliers
5.1.2 Bargaining Power Of Buyers
5.1.3 Threat Of New Entrants
5.1.4 Threat Of Substitutes
5.1.5 Intensity Of Rivalry
5.2 Value Chain Analysis
5.3 Pricing Analysis
Chapter 6. Global Osteosarcoma Market, By Type Of Service
To Be Continued…
Browse Full Report with TOC @
https://www.marketresearchfuture.com/reports/osteosarcoma-market-4412
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
